IHH Healthcare Berhad Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Prem Kumar Nair

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	1.3yrs
CEO sahipliği	n/a
Yönetim ortalama görev süresi	3yrs
Yönetim Kurulu ortalama görev süresi	1.9yrs

Son yönetim güncellemeleri

Recent updates

Some Shareholders Feeling Restless Over IHH Healthcare Berhad's (KLSE:IHH) P/E Ratio

Dec 31

Here's Why We Think IHH Healthcare Berhad (KLSE:IHH) Might Deserve Your Attention Today

Nov 19

Some Shareholders Feeling Restless Over IHH Healthcare Berhad's (KLSE:IHH) P/E Ratio

Aug 29

Returns On Capital Are Showing Encouraging Signs At IHH Healthcare Berhad (KLSE:IHH)

Jul 16

IHH Healthcare Berhad (KLSE:IHH) Shares Could Be 29% Below Their Intrinsic Value Estimate

Jun 24

Some Investors May Be Willing To Look Past IHH Healthcare Berhad's (KLSE:IHH) Soft Earnings

Jun 05

Do IHH Healthcare Berhad's (KLSE:IHH) Earnings Warrant Your Attention?

May 28

Unpleasant Surprises Could Be In Store For IHH Healthcare Berhad's (KLSE:IHH) Shares

May 13

IHH Healthcare Berhad (KLSE:IHH) Seems To Use Debt Quite Sensibly

Mar 17

Does IHH Healthcare Berhad (KLSE:IHH) Deserve A Spot On Your Watchlist?

Feb 25

Investors Will Want IHH Healthcare Berhad's (KLSE:IHH) Growth In ROCE To Persist

Feb 09

Estimating The Intrinsic Value Of IHH Healthcare Berhad (KLSE:IHH)

Jan 25

CEO

Prem Kumar Nair (63 yo)

1.3yrs

Görev süresi

Dr. Prem Kumar Nair serves as Non-Executive Director of Parkway Trust Management Limited a Manager of Parkway Life Real Estate Investment Trust since November 17, 2023. He serves as Vice Chairman of the Bo...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Prem Kumar Nair	Group Chief Executive Officer	1.3yrs	Veri yok	Veri yok
Dilip Kadambi	Group Chief Financial Officer	less than a year	Veri yok	Veri yok
Penelope Koh	Vice President of Investor Relations	no data	Veri yok	Veri yok
Nili Shayrina Saat	Group Head of Risk Management & Compliance	2yrs	Veri yok	Veri yok
Ida binti Ab Rahim	Group General Counsel	5.6yrs	Veri yok	Veri yok
Stephen Byrne	Group Head of Internal Audit	4yrs	Veri yok	Veri yok
Ashok Pandit	Group Chief Corporate Officer	3.4yrs	Veri yok	Veri yok
Jean-Francois Naa	Chief Executive Officer of HH Healthcare Malaysia	4.8yrs	Veri yok	Veri yok
Anurag Yadav	Chief Executive Officer of IHH Healthcare India	3yrs	Veri yok	Veri yok
Chorng Ann Chow	Chief Executive Officer of IHH Healthcare Singapore	1.3yrs	Veri yok	Veri yok
Kenneth Tsang	Regional Chief Executive Officer of IHH Healthcare North Asia	no data	Veri yok	Veri yok
Ching Seow	Company Secretary	no data	Veri yok	Veri yok

3.0yrs

Ortalama Görev Süresi

53yo

Ortalama Yaş

Deneyimli Yönetim: IHH 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Nik Norzrul Bin Nik Hassan Thani	Independent Non-Executive Chairman	less than a year	Veri yok	Veri yok
Muthanna Bin Abdullah	Independent Non-Executive Director	no data	RM 674.00k	Veri yok
Satoshi Tanaka	Independent Non-Executive Director	no data	RM 499.00k	Veri yok
Mehmet Aydinlar	Non-Independent & Non-Executive Director	13yrs	RM 399.00k	0.17% MYR 105.5m
Jill Watts	Independent Non-Executive Director	no data	RM 674.00k	Veri yok
Tomo Nagahiro	Non-Independent & Non-Executive Director	1.9yrs	RM 361.00k	Veri yok
Tsin-Lin Lim	Non Independent Non Executive Director	1.9yrs	Veri yok	Veri yok
Jia Mok	Non Independent & Non Executive Alternate Director	1.9yrs	Veri yok	Veri yok

1.9yrs

Ortalama Görev Süresi

63.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: IHH 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 1.9 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2025/01/10 21:35
Gün Sonu Hisse Fiyatı	2025/01/10 00:00
Kazançlar	2024/09/30
Yıllık Kazançlar	2023/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.

Analist Kaynakları

IHH Healthcare Berhad 40 Bu analistlerden 21, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Chee Chow	Affin Hwang Investment Bank
Lik Hsin Aw	Affin Hwang Investment Bank
Ken-Wern Lim	Affin Hwang Investment Bank

IHH Healthcare Berhad Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

IHH Healthcare Berhad Announces Resignation of Mohd Shahazwan Bin Mohd Harris as Non Independent and Non Executive Member of Nomination and Remuneration Committee

IHH Healthcare Berhad Announces the Appointment of Chua Bin Hwee as Independent and Non Executive Director, Effective August 14, 2024

IHH Healthcare Berhad Appoints Tan Sri Dr. Nik Norzrul Thani Bin N. Hassan Thani as Independent and Non Executive Chairman

IHH Healthcare Berhad Announces Retirement of Miss Ong Ai Lin as Independent and Non Executive Member of Risk Committee

IHH Healthcare Berhad Announces Retirement of Ong Ai Lin as Chairman of Audit Committee Independent and Non Executive, Effective 28 May 2024

High number of new directors

Recent updates

Some Shareholders Feeling Restless Over IHH Healthcare Berhad's (KLSE:IHH) P/E Ratio

Third quarter 2024 earnings released: EPS: RM0.061 (vs RM0.06 in 3Q 2023)

Here's Why We Think IHH Healthcare Berhad (KLSE:IHH) Might Deserve Your Attention Today

Is IHH Healthcare Berhad (KLSE:IHH) Trading At A 38% Discount?

IHH Healthcare Berhad to Report Q3, 2024 Results on Nov 28, 2024

IHH Healthcare Berhad's (KLSE:IHH) Returns On Capital Are Heading Higher

Upcoming dividend of RM0.045 per share

IHH Healthcare Berhad (KLSE:IHH) Seems To Use Debt Quite Sensibly

IHH Healthcare Berhad (KLSE:IHH) Has Announced A Dividend Of MYR0.045

First half dividend of RM0.045 announced

IHH Healthcare Berhad Declares Interim Single Tier Cash Dividend for the Financial Year Ending 31 December 2024, Payable on October 30, 2024

Second quarter 2024 earnings released: EPS: RM0.071 (vs RM0.034 in 2Q 2023)

Some Shareholders Feeling Restless Over IHH Healthcare Berhad's (KLSE:IHH) P/E Ratio

IHH Healthcare Berhad Announces Resignation of Mohd Shahazwan Bin Mohd Harris as Non Independent and Non Executive Member of Nomination and Remuneration Committee

IHH Healthcare Berhad Announces the Appointment of Chua Bin Hwee as Independent and Non Executive Director, Effective August 14, 2024

IHH Healthcare Berhad to Report Q2, 2024 Results on Aug 30, 2024

Returns On Capital Are Showing Encouraging Signs At IHH Healthcare Berhad (KLSE:IHH)

IHH Healthcare Berhad Appoints Tan Sri Dr. Nik Norzrul Thani Bin N. Hassan Thani as Independent and Non Executive Chairman

IHH Healthcare Berhad (KLSE:IHH) Shares Could Be 29% Below Their Intrinsic Value Estimate

Some Investors May Be Willing To Look Past IHH Healthcare Berhad's (KLSE:IHH) Soft Earnings

First quarter 2024 earnings released: EPS: RM0.087 (vs RM0.16 in 1Q 2023)

Do IHH Healthcare Berhad's (KLSE:IHH) Earnings Warrant Your Attention?

IHH Healthcare Berhad Announces Retirement of Miss Ong Ai Lin as Independent and Non Executive Member of Risk Committee

IHH Healthcare Berhad Announces Retirement of Ong Ai Lin as Chairman of Audit Committee Independent and Non Executive, Effective 28 May 2024

Unpleasant Surprises Could Be In Store For IHH Healthcare Berhad's (KLSE:IHH) Shares

IHH Healthcare Berhad to Report Q1, 2024 Results on May 29, 2024

High number of new directors

IHH Healthcare Berhad, Annual General Meeting, May 28, 2024

IHH Healthcare Berhad Appoints Dilip Kadambi as Group Chief Financial Officer

Ihh Healthcare Berhad Announces Resignation of Takeshi Akutsu as Non Independent and Non Executive Director, Effective March 31, 2024

Upcoming dividend of RM0.055 per share

IHH Healthcare Berhad (KLSE:IHH) Seems To Use Debt Quite Sensibly

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Does IHH Healthcare Berhad (KLSE:IHH) Deserve A Spot On Your Watchlist?

IHH Healthcare Berhad to Report Q4, 2023 Results on Feb 29, 2024

Investors Will Want IHH Healthcare Berhad's (KLSE:IHH) Growth In ROCE To Persist

IHH Healthcare Berhad Announces Cessation of Joerg Ayrle as Chief Financial Officer

Estimating The Intrinsic Value Of IHH Healthcare Berhad (KLSE:IHH)

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

IHH Healthcare Berhad to Report Q3, 2023 Results on Nov 30, 2023

IHH Healthcare Berhad Announces Joerg Ayrle, Group Chief Financial Officer to Remain on Garden Leave, Effective from 30 September 2023

Upcoming dividend of RM0.035 per share at 1.2% yield

New major risk - Revenue and earnings growth

IHH Healthcare Berhad Appoints Prem Kumar Nair as Group Chief Executive Officer, Effective from October 1, 2023

IHH Healthcare Berhad Declares Interim Dividend, Payable on October 27, 2023

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

IHH Healthcare Berhad to Report Q2, 2023 Results on Aug 29, 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of RM0.096 per share at 1.2% yield

IHH Healthcare Berhad to Report Q1, 2023 Results on May 31, 2023

IHH Healthcare Berhad Announces Special Cash Dividend, Payable on 30 June 2023

High number of new directors

Upcoming dividend of RM0.07 per share at 1.2% yield

Board Member exercised options to buy RM5.6m worth of stock.

Full year 2022 earnings released: EPS: RM0.17 (vs RM0.20 in FY 2021)

IHH Healthcare Berhad Announces Appointment of Mr. Takeshi Akutsu as Non Independent and Non Executive Member of Nomination and Remuneration Committee

IHH Healthcare Berhad Announces Resignation of Farid Bin Mohamed Sani as Non Independent and Non Executive Director

IHH Healthcare Berhad Appoints Tomo Nagahiro as Non-Independent and Non-Executive Director

IHH Healthcare Berhad to Report Q4, 2022 Results on Feb 28, 2023

IHH Healthcare Berhad Announces the Resignation of Tomo Nagahiro as Non Independent and Non Executive Alternate Director

IHH Healthcare Berhad Announces the Cessation of Takeshi Saito as Member of Nomination and Remuneration Committee, Effective January 27, 2023

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

IHH Healthcare Berhad to Report Q3, 2022 Results on Nov 29, 2022

Now 20% undervalued after recent price drop

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş